Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16363244rdf:typepubmed:Citationlld:pubmed
pubmed-article:16363244lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:16363244lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:16363244lifeskim:mentionsumls-concept:C1417215lld:lifeskim
pubmed-article:16363244lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:16363244lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:16363244lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:16363244lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:16363244lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:16363244pubmed:issue5lld:pubmed
pubmed-article:16363244pubmed:dateCreated2005-12-20lld:pubmed
pubmed-article:16363244pubmed:abstractTextMultimerin 1 (MMRN1) is a large, soluble, polymeric, factor V binding protein and member of the EMILIN protein family. In vivo, MMRN1 is found in platelets, megakaryocytes, endothelium and extracellular matrix fibers, but not in plasma. To address the mechanism of MMRN1 binding to activated platelets and endothelial cells, we investigated the identity of the major MMRN1 receptors on these cells using wild-type and RGE-forms of recombinant MMRN1. Ligand capture, cell adhesion, ELISA and flow cytometry analyses of platelet-MMRN1 binding, indicated that MMRN1 binds to integrins alphaIIbbeta3 and alphavbeta3. Endothelial cell binding to MMRN1 was predominantly mediated by alphavbeta3 and did not require the MMRN1 RGD site or cellular activation. Like many other alphavbeta3 ligands, MMRN1 had the ability to support adhesion of additional cell types, including stimulated neutrophils. Expression studies, using a cell line capable of endothelial-like MMRN1 processing, indicated that MMRN1 adhesion to cellular receptors enhanced its extracellular matrix fiber assembly. These studies implicate integrin-mediated binding in MMRN1 attachment to cells and indicate that MMRN1 is a ligand for alphaIIbbeta3 and alphavbeta3.lld:pubmed
pubmed-article:16363244pubmed:languageenglld:pubmed
pubmed-article:16363244pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16363244pubmed:citationSubsetIMlld:pubmed
pubmed-article:16363244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16363244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16363244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16363244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16363244pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16363244pubmed:statusMEDLINElld:pubmed
pubmed-article:16363244pubmed:monthNovlld:pubmed
pubmed-article:16363244pubmed:issn0340-6245lld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:KeltonJohn...lld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:CramerElisabe...lld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:MasséJean-Mar...lld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:SuehiroYoukoYlld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:HaywardCather...lld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:JeimySamira...lld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:ZhengShilunSlld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:AdamFrédérick...lld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:JoshiNileshNlld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:KeltonDavid...lld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:SandhuAminAlld:pubmed
pubmed-article:16363244pubmed:authorpubmed-author:SantosAurelio...lld:pubmed
pubmed-article:16363244pubmed:issnTypePrintlld:pubmed
pubmed-article:16363244pubmed:volume94lld:pubmed
pubmed-article:16363244pubmed:ownerNLMlld:pubmed
pubmed-article:16363244pubmed:authorsCompleteYlld:pubmed
pubmed-article:16363244pubmed:pagination1004-11lld:pubmed
pubmed-article:16363244pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:meshHeadingpubmed-meshheading:16363244...lld:pubmed
pubmed-article:16363244pubmed:year2005lld:pubmed
pubmed-article:16363244pubmed:articleTitleAnalyses of cellular multimerin 1 receptors: in vitro evidence of binding mediated by alphaIIbbeta3 and alphavbeta3.lld:pubmed
pubmed-article:16363244pubmed:affiliationDepartments of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.lld:pubmed
pubmed-article:16363244pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16363244pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:16363244pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:22915entrezgene:pubmedpubmed-article:16363244lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16363244lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16363244lld:pubmed